[{"id":"foundationone-cdx","kind":"drug","name":"FoundationOne CDx / Liquid CDx","route":"/drugs/foundationone-cdx/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"summary","before":"\"Foundation Medicine (Roche). Reports mutations, CNVs, fusions, TMB, MSI, and (tissue) HRD-LOH. Companion diagnostic for >30 therapies including olaparib, capivasertib, T-DXd (HER2 in NSCLC), and selpercatinib.\"","after":"\"FoundationOne CDx and Liquid CDx are Foundation Medicine's (Roche) comprehensive genomic profiling tests. They report mutations, CNVs, fusions, TMB, MSI, and (tissue) HRD-LOH. Companion diagnostic for >30 therapies i..."}]},{"id":"foundationone-cdx","kind":"drug","name":"FoundationOne CDx / Liquid CDx","route":"/drugs/foundationone-cdx/","commit":"815a2a8bae","date":"2026-09-05","author":"Jude Gomila","message":"OnCo: open map of oncology — corpus (642 objects, 14 kinds), graph, static site, API, TNBC spike","file":"src/data/drugs.ts","type":"added","fields":[{"field":"id"},{"field":"kind"},{"field":"name"},{"field":"modality"},{"field":"asOf"},{"field":"status"},{"field":"tldr"},{"field":"summary"},{"field":"mechanism"},{"field":"approvals"},{"field":"technologies"},{"field":"companies"}]}]